Behavioral and Functional Improvement Following Seizure Control in Dementia
Israel Medical Association Journal
; 24(7):482-484, 2022.
Article
in English
| EMBASE | ID: covidwho-1980591
chemical compound; escitalopram; hexamethylpropyleneamine oxime; lamotrigine; phenytoin; rivastigmine; tau protein; unclassified drug; adjustment disorder; adult; aged; alcohol consumption; Alzheimer disease; amnesia; anosmia; apathy; atrophy; behavior change; case report; clinical article; cognitive defect; dementia; depression; disease control; drug withdrawal; electroencephalogram; electroencephalography; epilepsy; epileptic state; frontal lobe epilepsy; hospitalization; human; irritability; leukomalacia; male; memory disorder; microangiopathy; Mini Mental State Examination; Montreal cognitive assessment; nuclear magnetic resonance imaging; REM sleep; review; SARS coronavirus; seizure; sensorimotor network; single photon emission computed tomography; sleep disorder; sweating; tachycardia; tonic clonic seizure
Search on Google
Collection:
Databases of international organizations
Database:
EMBASE
Language:
English
Journal:
Israel Medical Association Journal
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS